TY  - JOUR
AU  - Torres-Cornejo, A.
AU  - BenMarzouk-Hidalgo, O. J.
AU  - Viciana, P.
AU  - Sanchez, B.
AU  - Lopez-Ruz, M. A.
AU  - Lopez-Cortes, L. F.
AU  - Gutierrez-Valencia, A.
PY  - 2016
DO  - 10.1016/j.cmi.2015.09.028
SN  - 1198-743X
UR  - http://hdl.handle.net/10668/18746
T2  - Clinical microbiology and infection
AB  - Cross-sectional study comparing seminal human immunodeficiency virus type 1 (HIV-1) shedding in patients receiving boosted protease inhibitor monotherapy (mtPI/rtv) (n = 66) versus triple therapy (TT) (n = 61). Seminal HIV-1 shedding rates in patients...
LA  - en
PB  - Elsevier sci ltd
KW  - Human immunodeficiency virus 1 infection
KW  - human immunodeficiency virus 1 treatment
KW  - male genital tract
KW  - protease inhibitor monotherapy
KW  - triple therapy
KW  - Viral load
KW  - Blood-plasma
KW  - Hiv-1 rna
KW  - Semen
KW  - Lopinavir/ritonavir
KW  - Men
KW  - Ritonavir
TI  - Protease inhibitor monotherapy is effective in controlling human immunodeficiency virus 1 shedding in the male genital tract
TY  - research article
VL  - 22
ER  -